4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Congenital Heart Diseases
Congenital heart diseases represent a diverse group of structural abnormalities present from birth, impacting the heart's functionality and circulation. These conditions, ranging from atrial septal defects to more complex anomalies like hypoplastic left heart syndrome, often require early intervention. Advances in diagnostic tools, such as fetal echocardiography and genetic screening, have enabled earlier detection and better planning of treatment strategies. Surgical innovations, including minimally invasive techniques and hybrid procedures, continue to improve survival rates. Additionally, the long-term management of congenital heart diseases focuses on preventing complications, ensuring that patients lead healthier, more active lives through comprehensive and personalized care.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Miroslav Radenkovic
University of Belgrade, Serbia
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : A diabetic sweetheart facing a sour ending!
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile